Landfar Bio-medicine Co., Ltd (SHE:000504)
China
· Delayed Price · Currency is CNY 9.96
+0.47 (4.95%)
Mar 10, 2026, 3:04 PM CST
Landfar Bio-medicine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,132 | 2,756 | 3,614 | 3,627 | 5,795 | 3,814 | Upgrade
|
| Market Cap Growth | 2.71% | -23.76% | -0.34% | -37.42% | 51.96% | 51.48% | Upgrade
|
| Enterprise Value | 3,119 | 2,522 | 3,679 | 3,774 | 6,136 | 3,928 | Upgrade
|
| Last Close Price | 9.49 | 8.35 | 11.60 | 11.64 | 18.60 | 12.24 | Upgrade
|
| PE Ratio | - | - | - | - | - | 467.67 | Upgrade
|
| PS Ratio | 24.96 | 20.50 | 26.42 | 18.10 | 37.00 | 21.72 | Upgrade
|
| PB Ratio | 8.64 | 9.77 | 11.86 | 45.23 | 52.53 | 28.36 | Upgrade
|
| P/TBV Ratio | 17.60 | 11.81 | 14.20 | 696.61 | 726.09 | 276.47 | Upgrade
|
| P/FCF Ratio | 257.20 | - | 119.05 | 24.27 | 77.13 | - | Upgrade
|
| P/OCF Ratio | 206.04 | 574.87 | 99.63 | 21.80 | 54.11 | - | Upgrade
|
| EV/Sales Ratio | 24.86 | 18.76 | 26.90 | 18.84 | 39.18 | 22.38 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | - | 164.63 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 191.56 | Upgrade
|
| EV/FCF Ratio | 256.12 | - | 121.19 | 25.26 | 81.67 | - | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.09 | 0.67 | 2.95 | 2.83 | 2.02 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | - | 11.38 | Upgrade
|
| Debt / FCF Ratio | 10.66 | - | 6.72 | 1.58 | 4.16 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.37 | -0.65 | -0.96 | 0.21 | 1.44 | 1.52 | Upgrade
|
| Net Debt / EBITDA Ratio | 9.54 | 14.36 | 8.70 | -1.65 | -8.62 | 8.55 | Upgrade
|
| Net Debt / FCF Ratio | -10.96 | 13.65 | -9.61 | 0.11 | 2.11 | -0.96 | Upgrade
|
| Asset Turnover | 0.18 | 0.20 | 0.21 | 0.33 | 0.26 | 0.43 | Upgrade
|
| Inventory Turnover | 1.39 | 2.00 | 5.92 | 9.64 | 3.62 | 4.78 | Upgrade
|
| Quick Ratio | 1.18 | 1.18 | 1.41 | 0.89 | 0.68 | 0.69 | Upgrade
|
| Current Ratio | 1.42 | 1.32 | 1.45 | 0.91 | 0.98 | 1.15 | Upgrade
|
| Return on Equity (ROE) | -5.48% | -8.16% | -24.31% | -30.93% | -27.04% | 11.76% | Upgrade
|
| Return on Assets (ROA) | -1.41% | -1.39% | -3.45% | -1.33% | -2.26% | 3.11% | Upgrade
|
| Return on Invested Capital (ROIC) | -15.25% | -27.62% | -66.71% | -7.06% | -7.22% | 6.90% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.40% | -5.10% | -11.50% | -13.10% | -16.80% | 14.90% | Upgrade
|
| Earnings Yield | -0.20% | -0.72% | -0.78% | -0.34% | -0.33% | 0.21% | Upgrade
|
| FCF Yield | 0.39% | -0.49% | 0.84% | 4.12% | 1.30% | -5.55% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 13.78% | Upgrade
|
| Buyback Yield / Dilution | 0.62% | -5.67% | -0.51% | 2.30% | -17.27% | 13.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.